Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department

NCT04260607 is registered in ClinicalTrials.gov with Naval Medical Center Camp Lejeune as lead sponsor.

NCT NCT04260607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04260607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Initiating Ketamine in Acutely Suicidal Patients in the Emergency Department
Lead sponsor
Naval Medical Center Camp Lejeune
Phase
Phase 3
Overall status
Terminated
Start date
January 14, 2020
Completion date
February 16, 2022
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression severe, suicide, suicide threat